Publications by authors named "Paulo Rodriguez"

Claim this Profile
D
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma.
Francesco Di Meo, Francesca Albano, Annamaria Cesarano, Yunfei Wang, Brandon Kale, Paulo C Rodriguez

Cancer Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors.
Xuefeng Wang, Tingyi Li, Islam Eljilany, Alex Soupir, Michael Radmacher, Paulo C Rodriguez

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAp73 mediates anti-tumor immunity through regulation of lipid metabolism in the lung tumor microenvironment.
Hayley D Ackerman, Vanessa Y Rubio, Andrew J Davis, John H Lockhart, Nicole Hackel, Paulo C Rodriguez

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoma accelerates T cell and tissue aging.
Rebecca S Hesterberg, Joshua T Davis, Komal J Handoo, Aya G Elmarsafawi, Anthony C Augello, Paulo C Rodriguez

Cancer Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoplasmic reticulum stress responses in anticancer immunity.
Sung-Min Hwang, Shiun Chang, Paulo C Rodriguez, Juan R Cubillos-Ruiz

Nat Rev Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering synthetic agonists for targeted activation of Notch signaling.
David H Perez, Daniel Antfolk, Shiun Chang, Xiomar E Bustos, Elliot Medina, Paulo C Rodriguez

Nat Chem Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models.
Manali S Phadke, Jiannong Li, Sathya Sriramareddy, Paulo C Rodriguez, Brian Ruffell

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing.
Xiaoqing Yu, Michael D Jain, Meghan A Menges, Ling Cen, Jerald D Noble, Paulo C Rodriguez

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlling treatment toxicity in ovarian cancer to prime the patient for tumor extinction therapy.
Kit Gallagher, Rachel S Sousa, Chandler Gatenbee, Ryan Schenck, Peng Chen, Paulo Rodriguez

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation.
Alessio Ugolini, Alessandra De Leo, Xiaoqing Yu, Fabio Scirocchi, Xiaoxian Liu, Paulo C Rodriguez

Cancer Discov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors.
Jyoti Srivastava, Vipin K Yadav, Rachel V Jimenez, Pravin R Phadatare, Ninad A Inamdar, Paulo C Rodriguez

Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model.
Wael Gamal, Nienke B Goedhart, Helga Simon-Molas, Melanie Mediavilla-Varela, Angimar Uriepero-Palma, Paulo C Rodriguez

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma.
Marco Davila, Sae Bom Lee, Yun Pyo Kang, Justin Boucher, Jay Mandula, Paulo Rodriguez

Res Sq· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.
Roger Li, Nancy Y Villa, Xiaoqing Yu, Joseph O Johnson, Gustavo Borjas, Paulo C Rodriguez

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy.
Islam Eljilany, Sam Coleman, Aik Choon Tan, Martin D McCarter, John Carpten, Paulo Rodriguez

Cells· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgelin 2 guards T cell lipid metabolism and antitumour function.
Sung-Min Hwang, Deepika Awasthi, Jieun Jeong, Tito A Sandoval, Chang-Suk Chae, Paulo C Rodriguez

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering synthetic agonists for targeted activation of Notch signaling.
David H Perez, Daniel Antfolk, Xiomar E Bustos, Elliot Medina, Shiun Chang, Paulo C Rodriguez

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BatchFLEX: feature-level equalization of X-batch.
Joshua T Davis, Alyssa N Obermayer, Alex C Soupir, Rebecca S Hesterberg, Thac Duong, Paulo C Rodriguez

Bioinformatics· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer γδ TCR analysis uncovers clonotype diversity and prognostic potential.
Xiaoqing Yu, Li Song, Ling Cen, Biwei Cao, Ranran Tao, Paulo C Rodriguez

Cell Rep Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors.
Xuefeng Wang, Tingyi Li, Islam Eljilany, Vineeth Sukrithan, Aakrosh Ratan, Paulo C Rodriguez

medRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-cancer gamma delta T cell repertoire.
Xiaoqing Yu, Li Song, Ling Cen, Biwei Cao, Ranran Tao, Paulo C Rodriguez

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages.
Jay K Mandula, Rosa A Sierra-Mondragon, Rachel V Jimenez, Darwin Chang, Eslam Mohamed, Paulo C Rodriguez

Immunity· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma.
Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, Fabio Scirocchi, Delia Scocozza, Paulo C Rodriguez

Immunity· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to the special issue: B cells in cancer immunosurveillance.
Jose R Conejo-Garcia, Paulo C Rodriguez

Semin Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function.
Sung-Min Hwang, Deepika Awasthi, Jieun Jeong, Tito A Sandoval, Chang-Suk Chae, Paulo C Rodriguez

Res Sq· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis